food and drug administration fda

FDA Food Division Leader Quits

Head of FDA’s food division resigns following 89 “indiscriminate” staff layoffs

In his resignation letter, obtained by Bloomberg News, Jones cited “indiscriminate” layoffs to 89 staff members, including key technical experts. “I was looking forward to working to pursue the department’s agenda of improving the health of Americans by reducing diet-related chronic disease and risks from chemicals in food,” Jones wrote.

The Hill on MSN · 3d

FDA’s food safety head resigns over mass layoffs

Jim Jones, the head of the Food and Drug Administration’s (FDA) food division, resigned Monday, citing the mass firings of agency staff. According to a copy of his resignation letter viewed by

Wall Street Journal · 3d

FDA Food Division Leader Quits After Staff Layoffs

Jim Jones, a deputy commissioner at the U.S. Food and Drug Administration, resigned Monday following what he called the “indiscriminate firing” of nearly 90 staff members. “It has been increasingly cl

FDA, Wegovy and Ozempic

MarketWatch · 15h

FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.

We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.

CNN on MSN · 15h

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

USA TODAY on MSN · 16h

The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions

Mirum, FDA and Pharmaceuticals

Reuters · 13h

US FDA approves Mirum Pharma's genetic disorder drug

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first treatment for a rare condition that interferes with the body's ability to process cholesterol.

MarketWatch · 16h

FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease

The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first FDA-approved drug to treat CTX,

Business Insider · 16h

FDA approves Mirum treatment for cerebrotendinous xanthomatosis

The Food and Drug Administration approved Ctexli for the treatment of cerebrotendinous xanthomatosis in adults. “Ctexli is the first

15hon MSNOpinion

Senate Democrats press HHS over FDA firings

In letter, senators say recent staff firings could affect drug and device approval, food safety and public health threats.

19hon MSN

Snacks Recalled in 35 States as FDA Issues Warning

ZB Importing LLC has issued a recall for six varieties of Ülker snack rolls, biscuits and wafers due to undeclared wheat, ...

3don MSN

Trump Cuts Hit FDA Employees in Tobacco, Food Safety and Medical Devices

Probationary employees across the FDA received notices Saturday evening that their jobs were being eliminated, according to ...

13hon MSN

Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...

Food Safety News5h

FDA steps up import enforcement for pesticides, Salmonella and more import

The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and ...

1don MSN

Lawyer Kyle Diamantas Will Become Top Food Regulator at FDA

Attorney Kyle Diamantas is expected to be announced as the new deputy commissioner for human foods at the US Food and Drug ...

JD Supra15h

Make Food “Healthy” Again: FDA’s Resolution for a Healthier 2025

The U.S. Food and Drug Administration (FDA) began 2025 with a resolution to make food “healthy” again by announcing a trio of new final and ...

1don MSN

Top FDA food safety official's resignation letter warns firings will backfire on RFK Jr.

James Jones resigned as FDA deputy commissioner and said the Trump administration's "indiscriminate" job cuts show "disdain for the very people necessary to implement your agenda." ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA Food Division Leader Quits

FDA, Wegovy and Ozempic

Mirum, FDA and Pharmaceuticals

Related topics